Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Staphylococcus Aureus Bloodstream Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT03959345
What this trial is testing

Efficacy of Cloxacillin and Fosfomycin Combination Versus Cloxacillin Monotherapy in Patients With MSSA Bacteremia

Who this might be right for
Methicillin Susceptible Staphylococcus Aureus Septicemia
Miquel Pujol 215
Large-scale testing (Phase 3)Ended earlyNCT04160468
What this trial is testing

Direct Lysis of Staph Aureus Resistant Pathogen Trial of Exebacase

Who this might be right for
Staphylococcus Aureus BacteremiaStaphylococcus Aureus Endocarditis
ContraFect 259
Not applicableStudy completedNCT01431326
What this trial is testing

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Who this might be right for
AdenovirusAnesthesiaAnxiety+56 more
Daniel Benjamin 3,520
Post-approval studies (Phase 4)Looking for participantsNCT06650488
What this trial is testing

Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia

Who this might be right for
Staphylococcus Aureus EndocarditisStaphylococcus Aureus SepticemiaStaphylococcus Aureus Bloodstream Infection
Todd C. Lee MD MPH FIDSA 300
Testing effectiveness (Phase 2)Study completedNCT04775953
What this trial is testing

DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia

Who this might be right for
Staphylococcal Bacteraemia
National Institute of Allergy and Infectious Diseases (NIAID) 200
Post-approval studies (Phase 4)Ended earlyNCT00638157
What this trial is testing

Phase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE)

Who this might be right for
Infective Endocarditis
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 24
Testing effectiveness (Phase 2)Ended earlyNCT05225558
What this trial is testing

A Phase 2a Study, Effect of Vancomycin With vs Without Delpazolid (LCB01-0371) in Patients With MRSA Bacteremia

Who this might be right for
MRSA Bacteremia
LigaChem Biosciences, Inc. 40
Large-scale testing (Phase 3)Study completedNCT01898338
What this trial is testing

Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia

Who this might be right for
Staph Aureus Methicillin Resistant Bacteremia
Miquel Pujol 167
Large-scale testing (Phase 3)Study completedNCT00770341
What this trial is testing

MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002)

Who this might be right for
Staphylococcal Infection
Merck Sharp & Dohme LLC 122
Large-scale testing (Phase 3)Study completedNCT00093067
What this trial is testing

Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus

Who this might be right for
Bacterial EndocarditisBacteremia
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Testing effectiveness (Phase 2)WithdrawnNCT00505258
What this trial is testing

Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia

Who this might be right for
Bacteremia
Basilea Pharmaceutica
Early research (Phase 1)Study completedNCT02945241
What this trial is testing

Cystatin-C C-guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project

Who this might be right for
Methicillin-resistant Staphylococcus AureusSepsisCritical Illness
Mayo Clinic 399
Not applicableStudy completedNCT03029039
What this trial is testing

Platelet-associated Inflammation in Severe Sepsis

Who this might be right for
Severe Sepsis
Centre Hospitalier Universitaire de Saint Etienne 127
Not applicableStudy completedNCT03992703
What this trial is testing

Clinical Impact of Rapid AST Directly From Blood Cultures

Who this might be right for
Bacterial Infections
Fondation Hôpital Saint-Joseph 160
Not applicableStudy completedNCT03833102
What this trial is testing

Prospective Study of Staphylococcus Aureus Clinical Isolates Versus Colonization: RNAs as Potential Biomarkers for Bloodstream Infections

Who this might be right for
Staphylococcus Aureus
Rennes University Hospital 165
Not applicableStudy completedNCT01212601
What this trial is testing

Collect Clinical Data in Chinese Patients Received CUBICIN Treatment for Actual Usage in Clinical Practice

Who this might be right for
S. Aureus Bloodstream Infection
AstraZeneca 203
Testing effectiveness (Phase 2)Study completedNCT05184764
What this trial is testing

Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia

Who this might be right for
BacteremiaStaphylococcus AureusStaphylococcus Aureus Bacteremia+2 more
Armata Pharmaceuticals, Inc. 56
Large-scale testing (Phase 3)Ended earlyNCT00518687
What this trial is testing

Efficacy, Immunogenicity, and Safety of a Single Dose of V710 in Adult Patients Scheduled for Cardiothoracic Surgery (V710-003 AM2)

Who this might be right for
Staphylococcus AureusBacteremiaMediastinitis
Merck Sharp & Dohme LLC 8,031
Testing effectiveness (Phase 2)Study completedNCT00198302
What this trial is testing

Clinical Trial Comparing Safety and Pharmacokinetics of Standard Antibiotic Therapy, Plus Aurexis® or Placebo, for Treatment of Staphylococcus Aureus Bacteremia (SAB)

Who this might be right for
Staphylococcus Aureus Bacteremia
Bristol-Myers Squibb 60
Not applicableNo Longer AvailableNCT04597242
What this trial is testing

Expanded Access Study of Exebacase in COVID-19 Patients With Persistent MRSA Bacteremia

Who this might be right for
MRSA Bloodstream InfectionMRSA BacteremiaMRSA Right-sided Endocarditis+1 more
ContraFect
Next Page